News & Updates
Filter by Specialty:

Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS
01 Jul 2022
byAudrey Abella
Ultra-high-dose methylcobalamin (MeCbl) slowed functional decline in individuals with early-stage amyotrophic lateral sclerosis (ALS) with moderate progression, the JETALS* study has shown.
Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS
01 Jul 2022
Diabetes, fertility treatment, family history up autism risk in infants
26 Jun 2022
A recent Egypt study has identified several maternal and neonatal factors contributing to the risk of autism spectrum disorders (ASD) in infants, including the use of assisted fertility treatments, family medical history, and threatened abortion.